Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
UK regulator recommends changes to infant formula market
(Sharecast News) - The UK regulator has proposed a series of reforms to the infant formula market, including using plain packaging in hospitals and strengthening advertising rules, it was announced on Friday. Following a year-long investigation into the market, after accusations of high prices and limited choice, the Competition and Markets Authority found a combination of factors was leading to "poor outcomes" for parents.
In particular, it said families could save around £300 a year by switching to a cheaper brand without losing any nutritional benefits.
Sarah Cardell, chief executive of the CMA, said: "Many [parents] pick a brand at a vulnerable moment, based on incomplete information, often believing that higher prices must mean better quality. This is despite NHS advice stating that all brands will meet your baby's nutritional needs, regardless of brand or price.
"Our proposals are designed to help parents make the best choices for them and their babies.
"Our proposals will also make it easier for regulations to be property enforced, while ensuring manufacturers and retailers can be more confident in what they can and can't do according to law."
One of its core recommendations is removing brand influence in healthcare settings.
Formula manufactures - including Aptamil-owner Danone and Nestle, owner of SMA - are already heavily restricted in the UK when it comes to the advertising and promotion of baby milk, as part of wider attempts to encourage breastfeeding.
They therefore place "significant emphasis" on building brand awareness to secure customers instead, the CMA found.
The CMA has therefore recommended that when formula is given in healthcare settings, labelling should be standardised, either though non-branded containers or a white label formula specifically for the NHS.
It also recommended strengthening labelling and advertising rules.
"Claims that are intangible, or cannot easily be checked by parents, should be banned," the CMA said. "Like infant formula, advertising - including price promotions and deals - for follow-on milks should be banned."
Companies are currently banned from advertising baby formula as an alternative to breastfeeding, but are allowed to promote so-called "follow-on" products from six months.
The CMA opted against putting a price cap on formula, however, as it warned it could push up the prices of cheaper formulas as well as disincentivising breastfeeding.
But it said parents should be allowed to use vouchers, loyalty points and other coupons to buy formula. Breast feeding rates are lower among parents on lower incomes, meaning they are disproportionately affected.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.